SRP COMPOUND INTELLIGENCE

Adamax Research Guide

An evidence-mapped overview of the marketplace name Adamax covering what the live product page actually states, negative registry and literature lookups, a documented optimizer homonym, and why Semax papers cannot be re-labeled as Adamax evidence. Sequence is not established.

Identity uncertain Not Semax No indexed Adamax peptide papers Research use only

Explore the Evidence Adamax 10 mg vial

Educational information only. Adamax is not an FDA-approved drug for human use. Laboratory research use only; not for human or animal use. Identity / evidence uncertain. No human dosing, reconstitution, or administration protocol appears on this page.

01 / Identity

Quick Facts

Opened registry and literature lookups do not establish Adamax as a single indexed peptide. The live Simple Research Peptides page (Adamax 10 mg Research Compound Vial, fetched 16 August 2026) lists 10 mg lyophilized research material in the Brain & Mind Research category (SKU ADAMAX-10MG). That page claims ≥99% purity, a COA, Made in the USA, and third-party testing, and states: “For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.” It published no amino-acid sequence, no CAS, no formula, no PubChem CID, and no UNII.

Registry payloads opened the same day:

PubChem PUG REST name lookup name=Adamax: HTTP 404. No Adamax compound record.
FDA/NCATS GSRS substances search q=Adamax: total 0, content [].
ClinicalTrials.gov v2 API query.term=Adamax: {"studies":[]}.
PubMed term=Adamax: 39 hits. The hit opened here, PMID 42236259 (Sawant & Ghongade, 2026, Diabetes Obes Metab), is an AdaMax optimizer paper, not a peptide.
Peptide-restricted PubMed queries (Adamax+peptide OR Adamax+Semax OR "N-acetyl-Semax" adamantane; Title/Abstract Adamax AND (peptide OR Semax OR adamantane); N-acetyl-Semax / "N-acetyl Semax" / "acetyl-Semax"): 0 items.

Related but distinct — Semax, not Adamax. PubChem CID 9811102 is a Semax record (formula C₃₇H₅₁N₉O₁₀S, MW 813.9, InChIKey AFEHBIGDWIGTEH-AQRCPPRCSA-N). Synonyms on that record include Semax, 80714-61-0, ACTH (4-7), Pro-Gly-Pro-, I5FAL2585H, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro, H-Met-Glu-His-Phe-Pro-Gly-Pro-OH, UNII-I5FAL2585H. Dmitrieva et al. (2010) describe Semax as consisting of ACTH(4-7) plus C-terminal PGP and report a rat pMCAO neurotrophin-transcription study (PMID 19633950; PMCID PMC11498467). That is Semax evidence, not Adamax evidence.

Marketplace nameAdamaxSRP 10 mg vial page fetched

SequenceNOT ESTABLISHEDSRP page silent; no registry sequence

CASNone foundNo Adamax CAS in opened lookups

PubChemNone foundPUG REST name=Adamax → HTTP 404

UNIINone foundNo Adamax UNII in opened lookups

GSRS0 substancesFDA/NCATS search q=Adamax

ClinicalTrials.gov0 studiesv2 API query.term=Adamax

Indexed peptide papersNone foundPeptide / Semax / adamantane filters = 0

Related but distinctSemax (MEHFPGP)CID 9811102; CAS 80714-61-0; UNII I5FAL2585H

Opened Adamax-named hitOptimizer homonymPMID 42236259 — not a peptide

ApprovalNone identifiedNo GSRS substance; no trials

Evidence baseIdentity uncertainResearch use only

Critical identity point: A trade-style name is not a structure. Public vendor and encyclopedia write-ups disagree on what “Adamax” is. Those write-ups are marketing, not evidence, and they cannot all describe the same molecule. This page does not pick a winner and does not invent a sequence.

02 / Overview

What the name is — and is not

Adamax, as sold on the fetched SRP page, is a trade-style marketplace name for a 10 mg lyophilized research-compound vial. The live page does not disclose a sequence, CAS, formula, PubChem CID, or UNII. This review cannot assign a mechanism, receptor, or pharmacologic class to that name. Mechanism follows identity. Identity is not documented in the opened registries or in an indexed Adamax peptide paper.

Semax is a related but distinct heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) with its own PubChem record (CID 9811102) and one opened primary paper (PMID 19633950). Semax is not Adamax. Marketplace copy that treats Adamax as “a stronger Semax,” “N-acetyl Semax,” or “adamantane-Semax” is not a substitute for a disclosed structure plus a paper that used that structure.

The only PubMed record opened under the bare term Adamax in this review is an optimizer homonym (PMID 42236259), not a peptide study.

Sequence / identity problem. The SRP page is silent. Some public vendor pages call Adamax N-adamantyl-Semax (Ad-MEHFPGP); some call it a 9-residue Ac-MEHFPGPAG-NH₂ with C-terminal adamantane; some equate it with N-Acetyl Semax Amidate (Ac-MEHFPGP-NH₂) and omit adamantane. Those three structures cannot all be the same molecule. Mentioned only to show that a name alone is not a structure — not as facts, and not as the SRP vial.

03 / Mechanism

Cannot be assigned until identity is documented

There is no invented receptor diagram and no fake chart on this page. Observed means a payload actually opened. Related / distinct means Semax, not Adamax. Marketing means vendor copy, not a paper. Not shown means this review did not open such a paper.

Not found — Adamax peptide

No assignable pathway

No opened paper administered a peptide named Adamax. No receptor, transporter, enzyme, or signaling cascade can be assigned to an undisclosed structure.

Observed — optimizer homonym

AdaMax is not a peptide here

Sawant & Ghongade (2026) use “AdaMax” as a machine-learning optimizer in a glucose-dynamics / diabetes-management network paper (PMID 42236259). Name collision, not peptide pharmacology.

Related but distinct — Semax

Neurotrophin transcription is Semax data

Dmitrieva et al. (2010): Semax (ACTH(4-7) + C-terminal PGP) and Pro-Gly-Pro activated transcription of neurotrophins and their receptor genes after cerebral ischemia in a rat pMCAO model (PMID 19633950). The opened abstract’s stroke-therapy sentence is about Semax. It is not an Adamax clinical claim.

Marketing — not assigned

BBB / BDNF / “stronger Semax”

Vendor claims that Adamax crosses the blood–brain barrier, raises BDNF, or is a more stable Semax analogue are unsourced relative to the opened record. They require a disclosed structure and a paper that used that structure.

Not shown in a paper opened here

Gaps that block a mechanism

No Adamax peptide sequence, CAS, formula, or registry ID. No Adamax peptide binding table, PK curve, or in-vivo study. No human cognition outcomes. No BBB, BDNF, or adamantane-PK results with Adamax. No equivalence to Semax or N-acetyl Semax amidate.

Observed — product page only

What the vial listing actually says

10 mg lyophilized research material; Brain & Mind Research; laboratory/research only. No sequence on the fetched page. Purity and COA claims on a product page are not a mechanism and are not a literature identity.

Do not paste Semax neurotrophin results, an optimizer paper, or an unopened vendor BBB / BDNF / cognition claim onto this marketplace name. Mechanism cannot be assigned until identity is documented.

04 / Research Map

Where the record actually sits

Label every cluster. Adamax peptide would mean a paper that named Adamax as the test article. Not found means this review did not open such a paper. Related but distinct means Semax.

Identity / registry — negative lookups

No compound record

PubChem name=Adamax: HTTP 404. GSRS q=Adamax: 0 substances. ClinicalTrials.gov query.term=Adamax: 0 studies. SRP page: 10 mg lyophilized research material; no sequence, CAS, formula, PubChem, or UNII.

Marketplace conflict — marketing, not evidence

Three incompatible write-ups

Some pages: N-adamantyl-Semax (Ad-MEHFPGP). Some: 9-residue Ac-MEHFPGPAG-NH₂ with C-terminal adamantane. Some: N-Acetyl Semax Amidate (Ac-MEHFPGP-NH₂), no adamantane. A name alone is not a structure. This page does not pick a winner.

Homonym literature

AdaMax optimizer

PubMed term=Adamax returned 39 hits. The opened paper is Sawant & Ghongade 2026, a diabetes / glucose-dynamics network study using the AdaMax optimizer (PMID 42236259). Not a peptide.

Related but distinct — Semax

Registry + one opened paper

PubChem CID 9811102: Semax; C37H51N9O10S; MW 813.9; MEHFPGP; CAS 80714-61-0; UNII I5FAL2585H. Dmitrieva 2010: Semax + PGP, rat pMCAO neurotrophin transcription (PMID 19633950). Do not re-label as Adamax.

Adamax peptide papers — not found

Filtered PubMed = 0

Adamax+peptide OR Adamax+Semax OR “N-acetyl-Semax” adamantane: 0 items. Title/Abstract Adamax AND (peptide OR Semax OR adamantane): 0 items. N-acetyl-Semax name variants: 0 items.

Cognition / BBB / BDNF / stacks — not found

Unsourced for this name

No opened Adamax peptide paper measured human cognition, blood–brain-barrier penetration, BDNF, or adamantane PK. No opened combination-product paper. Semax neurotrophin data remain Semax data.

05 / Evidence Snapshot

What was studied, in what system

Read the “compound actually studied” column first. Published study designs are historical facts from those papers. They are not a protocol.

Domain	Compound actually studied	System	Status	Source
Marketplace listing	Name “Adamax”; 10 mg lyophilized vial	SRP product page, fetched 16 Aug 2026	Trade name; no sequence	SRP product URL
PubChem name lookup	Query name=Adamax	PUG REST property	HTTP 404; no record	PubChem PUG REST
FDA/NCATS substance	Query q=Adamax	GSRS substances search	0 substances	FDA/NCATS GSRS
Clinical trials	Query term=Adamax	ClinicalTrials.gov v2 API	0 studies	ClinicalTrials.gov
PubMed name search	Term=Adamax (39 hits)	Bibliographic index	Opened hit is not a peptide	PMID 42236259
Optimizer homonym	AdaMax optimizer	Diabetes / glucose-dynamics network paper	NOT A PEPTIDE	PMID 42236259
Peptide-filtered PubMed	Adamax + peptide / Semax / adamantane	Title/Abstract and combined queries	0 items	PubMed esearch
N-acetyl-Semax PubMed	N-acetyl-Semax name variants	Bibliographic index	0 items	PubMed esearch
Semax registry	Semax (MEHFPGP)	PubChem CID 9811102	Related but distinct	CID 9811102
Semax neurotrophin transcription	Semax and Pro-Gly-Pro	Rat pMCAO	RELATED BUT DISTINCT	PMID 19633950
Adamax peptide pharmacology	—	—	Not found	This review

06 / Timeline

How the opened record sits

2010 — Semax paper opened (related but distinct)

Not an Adamax study

Dmitrieva et al.: Semax and Pro-Gly-Pro activate neurotrophin and receptor-gene transcription after cerebral ischemia in the rat; opened abstract frames Semax as ACTH(4-7) + PGP (PMID 19633950). Semax evidence only.

Undated marketplace write-ups — not evidence

Three incompatible “Adamax” structures

Vendor / encyclopedia pages disagree: N-adamantyl-Semax (Ad-MEHFPGP); 9-residue Ac-MEHFPGPAG-NH₂ plus C-terminal adamantane; N-Acetyl Semax Amidate without adamantane. Flagged as marketing. Not used as structure.

2026 — AdaMax optimizer homonym

Opened PubMed Adamax hit is not a peptide

Sawant & Ghongade, Diabetes Obes Metab: glucose-dynamics analysis network paper using the AdaMax optimizer (PMID 42236259).

16 August 2026 — This review

Negative peptide identity lookups

SRP product page fetched (10 mg lyophilized research material; no sequence). PubChem name=Adamax 404. GSRS 0. ClinicalTrials.gov 0. Peptide-restricted PubMed 0. Semax CID 9811102 opened only as a related-but-distinct record.

07 / Limits

What is not established

These are gaps in the opened record. Treating any of them as settled is incorrect.

Sequence is not established

The SRP page does not give a sequence. PubChem, GSRS, and UNII lookups for Adamax returned nothing. Vendor write-ups that assign Ad-MEHFPGP, Ac-MEHFPGPAG-NH₂-plus-adamantane, or Ac-MEHFPGP-NH₂ are incompatible with each other and are not evidence.

Not Semax

Semax has a PubChem record (CID 9811102) and an opened primary paper (PMID 19633950). Adamax does not inherit Semax identity, Semax stroke-therapy framing, or Semax neurotrophin results.

No indexed Adamax peptide papers

Peptide-, Semax-, and adamantane-restricted PubMed queries returned 0 items. The opened Adamax-named paper is an optimizer homonym (PMID 42236259).

Human cognition is not established

No opened paper reports human memory, focus, attention, mood, or “nootropic” outcomes with a peptide named Adamax.

BBB, BDNF, and adamantane-PK claims are not established

No opened Adamax peptide paper measured blood–brain-barrier penetration, BDNF/NGF, or adamantane-related pharmacokinetics. The opened neurotrophin paper used Semax.

Semax equivalence is not established

Even if a future COA disclosed a Semax-related conjugate, that would still not make Semax papers into Adamax papers. The three circulating vendor structures are not the same molecule.

No approved therapeutic use

No GSRS substance, no ClinicalTrials.gov study, no FDA-approved finished drug in the sources opened here. The SRP page is research-use only.

No human dosing on this page

There is no human dosing, reconstitution, or administration protocol here. Research-use only; not an FDA-approved drug for human use.

Popular claim	Status after this review
“Adamax is N-adamantyl-Semax (Ad-MEHFPGP)”	Marketing, not evidence. One of three incompatible vendor structures. SRP page silent.
“Adamax is Ac-MEHFPGPAG-NH₂ with C-terminal adamantane”	Marketing, not evidence. Incompatible with the other two write-ups.
“Adamax is N-Acetyl Semax Amidate (no adamantane)”	Marketing, not evidence. Omits adamantane; cannot be the same molecule as the adamantane write-ups.
“Same thing as Semax”	False as identity. Semax is CID 9811102 / MEHFPGP. Adamax has no opened record.
“Published Adamax peptide papers / BDNF / BBB”	Not found in opened Adamax peptide searches. Semax neurotrophin data are Semax data.
“Human cognition / nootropic peptide”	Not found in a paper opened here.
“Indexed clinical trials”	ClinicalTrials.gov v2: 0 studies.
Marketplace vial = a registered peptide	Not established. Sequence, MS identity, and distinction from Semax-family names must be documented analytically.

If a claim requires swapping Semax, N-acetyl Semax amidate, an unspecified adamantane conjugate, or an optimizer paper for Adamax peptide data, it is not established on this page.

08 / Selected studies

Primary records in this map

Every PMID below is from the verified set used to build this page. Allowed PMIDs on this page: 42236259 and 19633950 only.

NOT A PEPTIDE / OPTIMIZER HOMONYM

Sawant & Ghongade, 2026 — Diabetes Obes Metab

Opened under PubMed term=Adamax. Title begins “Diabetes Management Through Glucose Dynamics Analysis Network…”. The Adamax string in this hit is the AdaMax optimizer, not a peptide. PMID 42236259. Do not cite as Adamax peptide evidence.

RELATED BUT DISTINCT — Semax, not Adamax

Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV, 2010 — Cell Mol Neurobiol

Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Rat pMCAO study. Opened abstract: “Consisting of a fragment of ACTH(4-7) and C-terminal PGP tripeptide, the polypeptide Semax is successfully used for acute stroke therapy.” PMID 19633950. doi: 10.1007/s10571-009-9432-0. PMCID PMC11498467. This is Semax evidence, not Adamax.

09 / Laboratory

Research-only caution

Adamax, as listed on the fetched SRP page, is a research-compound marketplace name. It is not an FDA-approved drug for human use. This page is educational. It does not provide dosing, reconstitution, administration, or any human-use instructions.

SRP material is for laboratory research only. It is not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.

Laboratory identity is the first practical issue — and it is unresolved. Before treating a vial as a literature compound:

Require sequence disclosure (full residue string, termini, and any N- or C-terminal modification). A trade name is not enough.
Require a COA with mass spectrometry (and complementary identity methods) that matches the disclosed sequence. Purity percentage alone does not identify the molecule.
Distinguish the lot from Semax (MEHFPGP; CID 9811102; CAS 80714-61-0; UNII I5FAL2585H), from N-acetyl Semax amidate (Ac-MEHFPGP-NH₂ as used in some vendor write-ups), and from adamantane conjugates (Ad-MEHFPGP or a 9-residue adamantane write-up). Those names are not interchangeable.
Do not import Semax methods, Semax neurotrophin readouts, or Semax stroke-therapy framing onto an unidentified vial.

No reconstitution scheme, no administration route, and no human or veterinary use protocol appears on this page. Research use only.

10 / FAQ

Common questions

What is Adamax?

A marketplace / trade-style name. The fetched SRP page lists a 10 mg lyophilized research-compound vial (Brain & Mind Research; SKU ADAMAX-10MG) and does not give a sequence, CAS, formula, PubChem CID, or UNII. Opened registries returned no Adamax compound. Identity is uncertain.

Is it the same as Semax?

No. Semax is a documented heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro; PubChem CID 9811102). Adamax has no opened compound record. Semax papers are not Adamax papers.

What sequence is reported?

None established in opened sources. The SRP page is silent. Public vendor write-ups disagree (N-adamantyl-Semax vs a 9-residue adamantane conjugate vs N-Acetyl Semax Amidate without adamantane). Those cannot all be the same molecule. This page does not invent a sequence.

Are there published Adamax peptide papers?

Not in the opened, peptide-restricted PubMed searches (0 items). A bare “Adamax” search hit opened here is an AdaMax optimizer paper (PMID 42236259), not a peptide.

Did this review find clinical trials?

No. ClinicalTrials.gov v2 API query.term=Adamax returned no studies. GSRS search returned 0 substances.

Does Adamax raise BDNF, cross the BBB, or improve cognition?

Not established in an opened Adamax peptide paper. The opened neurotrophin-transcription paper used Semax (PMID 19633950).

Is Adamax FDA-approved?

No. Educational information only. Not an FDA-approved drug for human use. Research compound listing only.

Does this page include human dosing?

No. There is no human dosing, reconstitution, or administration protocol on this page.

11 / References

Citations used on this page

Full citations for the verified set. Each line is a paper or registry record actually opened for this page. One-line findings are from those opened abstracts or API payloads. Allowed PMIDs: 42236259 and 19633950 only.

Sawant & Ghongade. Diabetes Management Through Glucose Dynamics Analysis Network… Diabetes Obes Metab. 2026. PMID 42236259. Opened as the PubMed term=Adamax hit. AdaMax optimizer — not a peptide.
Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2010;30(1):71-9. doi: 10.1007/s10571-009-9432-0. PMID 19633950. PMCID PMC11498467. Rat pMCAO neurotrophin transcription. Semax, not Adamax.
PubChem PUG REST name=Adamax property lookup: HTTP 404. No Adamax compound record.
PubChem CID 9811102 (Semax, related but distinct): C37H51N9O10S; MW 813.9; InChIKey AFEHBIGDWIGTEH-AQRCPPRCSA-N; synonyms include Semax, 80714-61-0, I5FAL2585H, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro, UNII-I5FAL2585H. https://pubchem.ncbi.nlm.nih.gov/compound/9811102
FDA/NCATS GSRS substances search q=Adamax: total 0, content [].
ClinicalTrials.gov v2 API query.term=Adamax: {“studies”:[]}.
PubMed esearch term=Adamax: 39 hits; opened hit is PMID 42236259 (optimizer). Peptide-restricted and N-acetyl-Semax queries: 0 items.
Simple Research Peptides. Adamax 10 mg Research Compound Vial product page. http://simpleresearchpeptides.com/product/adamax-10-mg-vial/ Fetched 16 August 2026. Listed 10 mg lyophilized research material. Research use only.
Simple Research Peptides. Semax 10 mg vial (related listing; distinct peptide). http://simpleresearchpeptides.com/product/semax-10-mg-vial/
Simple Research Peptides. Compound Research Guides directory. http://simpleresearchpeptides.com/research-compound-directory/compound-research-guides/

Sources searched but not used as evidence: public vendor / encyclopedia pages that call Adamax N-adamantyl-Semax (Ad-MEHFPGP), a 9-residue Ac-MEHFPGPAG-NH₂ with C-terminal adamantane, or N-Acetyl Semax Amidate (Ac-MEHFPGP-NH₂) — flagged as marketing, not evidence, and not cited as structure; any Semax paper other than the opened PMID 19633950; price and sales copy from the product page, except as a fetch note that the live page listed 10 mg lyophilized research material.

Educational information only. Adamax is not an FDA-approved drug for human use. Identity / evidence uncertain. Laboratory research use only; not for human or animal use. Last source review: 16 August 2026 (America/Indianapolis). Product URL, PubChem, GSRS, ClinicalTrials.gov, and PubMed queries were opened the same day. Allowed PMIDs: 42236259, 19633950.